Five Star Equities Issues New Research Reports on FSL, MRIN, NSPH and ZGNX


Follow this company

Companies Mentioned

NYSE:FSL / NYSE:MRIN / NASDAQ:NSPH / NASDAQ:ZGNX
02/13/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Freescale Semiconductor Ltd. (NYSE: FSL) shares spiked 9.33 percent to close at $20.50 a share Wednesday. The stock traded between $19.38 and $20.56 on volume of 24.45 million shares traded. The company announced that its previously announced public offering has been upsized to 35.0 million common shares and priced at $18.50 per share. Shares of Freescale Semiconductor are up approximately 27.0 percent year-to-date.

Get more information on Freescale Semiconductor and free access to the in-depth equity report at:  
www.FiveStarEquities.com/FSL

Marin Software Inc. (NYSE: MRIN) shares surged 14.10 percent to close at $11.25 a share Wednesday. The stock traded between $10.13 and $11.49 on volume 1.24 million shares traded. The company reported net revenues were $21.8 million for the fourth quarter of 2013, an increase of 28.0 percent when compared to a year ago. Shares of Marin Software are up approximately 10.0 percent year-to-date.

Get more information on Marin Software free access to the in-depth equity report at:  
www.FiveStarEquities.com/MRIN

Nanosphere, Inc. (NASDAQ: NSPH) shares jumped 10.23 percent to close at $2.37 a share Wednesday. The stock traded between $2.17 and $2.54 on volume of 1.44 million shares traded. The company reported record revenues of $3.4 million for the fourth quarter of 2013, compared to $1.6 million a year ago. Shares of Nanosphere are up approximately 3.5 percent year-to-date.

Get more information on Vical and free access to the in-depth equity report at:  
www.FiveStarEquities.com/VICL

Zogenix, Inc. (NASDAQ: ZGNX) shares gained 9.86 percent to close at $4.84 a share Wednesday. The stock traded between $4.46 and $4.87 on volume 5.50 million shares traded. The company announced the formation of an External Safe-Use Board for Zohydro (hydrocodone bitartrate) extended-release capsules. Shares of Zogenix are up approximately 40.0 percent year-to-date.

Get more information on Zogenix and free access to the in-depth equity report at:  
www.FiveStarEquities.com/ZGNX

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:          
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *